Filing Details
- Accession Number:
- 0000874015-17-000067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-17 17:57:00
- Reporting Period:
- 2017-11-15
- Accepted Time:
- 2017-11-17 17:57:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Ionis Pharmaceuticals Inc | IONS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206369 | Iii Joseph Klein | C/O Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-15 | 2,250 | $28.47 | 9,377 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-15 | 2,250 | $53.56 | 7,127 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-11-16 | 2,812 | $12.94 | 9,939 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Employee Director Stock Option (right to buy) | Disposition | 2017-11-15 | 2,250 | $0.00 | 2,250 | $28.47 |
| Common Stock | Non-Employee Director Stock Option (right to buy) | Disposition | 2017-11-16 | 2,812 | $0.00 | 2,812 | $12.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,000 | 2017-07-01 | 2023-06-30 | No | 4 | M | Direct |
| 0 | 2016-07-02 | 2022-07-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100 | Indirect | By son |
Footnotes
- Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 10/11/2017.
Billionaire Hedge Funds
